A quick pointer to an article on The Guardian that takes an in-depth look at drugs that enhance cognitive performance:

In 2004 he coined the term “cosmetic neurology” to describe the practice of using drugs developed for recognised medical conditions to strengthen ordinary cognition. Chatterjee worries about cosmetic neurology, but he thinks that it will eventually become as acceptable as cosmetic surgery; in fact with neuroenhancement it’s harder to argue that it’s frivolous. As he notes in a 2007 paper: “Many sectors of society have winner-take-all conditions in which small advantages produce disproportionate rewards.” At school and at work, the usefulness of being “smarter”, needing less sleep and learning more quickly is “abundantly clear”. In the near future, he predicts, some neurologists will refashion themselves as “quality-of-life consultants” whose role will be “to provide information while abrogating final responsibility for these decisions to patients”. The demand is certainly there: from an ageing population that won’t put up with memory loss; from overwrought parents bent on giving their children every possible edge; from anxious employees in an efficiency-obsessed, BlackBerry-equipped office culture where work never really ends.